270 related articles for article (PubMed ID: 33068649)
21. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
22. Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling.
Wang W; Liu F; Wang C; Wang C; Tang Y; Jiang Z
Med Sci Monit; 2018 Mar; 24():1282-1294. PubMed ID: 29500337
[TBL] [Abstract][Full Text] [Related]
23. Self-seeding circulating tumor cells promote the proliferation and metastasis of human osteosarcoma by upregulating interleukin-8.
Liu T; Ma Q; Zhang Y; Wang X; Xu K; Yan K; Dong W; Fan Q; Zhang Y; Qiu X
Cell Death Dis; 2019 Jul; 10(8):575. PubMed ID: 31366916
[TBL] [Abstract][Full Text] [Related]
24. Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells.
Lai HC; Yeh CC; Jeng LB; Huang SF; Liao PY; Lei FJ; Cheng WC; Hsu CL; Cai X; Chang C; Ma WL
Oncotarget; 2016 Jul; 7(29):46448-46465. PubMed ID: 27340775
[TBL] [Abstract][Full Text] [Related]
25. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer.
Yao J; Feng J; Gao X; Wei D; Kang T; Zhu Q; Jiang T; Wei X; Chen J
Biomaterials; 2017 Jan; 113():1-17. PubMed ID: 27794222
[TBL] [Abstract][Full Text] [Related]
26. Maimendong and Qianjinweijing Tang (Jin formula) suppresses lung cancer by regulation of miR-149-3p.
Jiang Z; Ma Y; Tian T; Sun Y; Chen H; Lu Y; Wu Y; Jiang H; Li W; Li L; Zhou H; Wu M
J Ethnopharmacol; 2020 Aug; 258():112836. PubMed ID: 32344160
[TBL] [Abstract][Full Text] [Related]
27. Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis.
Tsai YF; Huang CC; Lin YS; Hsu CY; Huang CP; Liu CY; Chiu JH; Tseng LM
Cancer Immunol Immunother; 2021 Aug; 70(8):2339-2351. PubMed ID: 33512556
[TBL] [Abstract][Full Text] [Related]
28. Carvedilol suppresses migration and invasion of malignant breast cells by inactivating Src involving cAMP/PKA and PKCδ signaling pathway.
Dezong G; Zhongbing M; Qinye F; Zhigang Y
J Cancer Res Ther; 2014; 10(4):998-1003. PubMed ID: 25579542
[TBL] [Abstract][Full Text] [Related]
29. Ziyuglycoside II suppresses the aggressive phenotype of triple negative breast cancer cells through regulating Src/EGFR-dependent ITGB4/FAK signaling.
Wang K; Zou P; Zhu X; Zhang T
Toxicol In Vitro; 2019 Dec; 61():104653. PubMed ID: 31525383
[TBL] [Abstract][Full Text] [Related]
30. Circulating Tumor Cell Migration Requires Fibronectin Acting through Integrin B1 or SLUG.
Huaman J; Ogunwobi OO
Cells; 2020 Jul; 9(7):. PubMed ID: 32630254
[TBL] [Abstract][Full Text] [Related]
31. [Effect of celastrol in inhibiting metastasis of lung cancer cells by influencing Akt signaling pathway and expressing integrins].
Xu J; Wu CL; Huang J
Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1129-33. PubMed ID: 26226758
[TBL] [Abstract][Full Text] [Related]
32. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.
Qi LN; Xiang BD; Wu FX; Ye JZ; Zhong JH; Wang YY; Chen YY; Chen ZS; Ma L; Chen J; Gong WF; Han ZG; Lu Y; Shang JJ; Li LQ
Cancer Res; 2018 Aug; 78(16):4731-4744. PubMed ID: 29915159
[TBL] [Abstract][Full Text] [Related]
33. Jinfukang inhibits lung cancer metastasis by regulating T cell receptors.
Luo B; Wang P; Tian J; Chu X; Lu X; Yang Y; Zhou Y; Li Y; Que Z
J Ethnopharmacol; 2024 Jan; 318(Pt A):116885. PubMed ID: 37422099
[TBL] [Abstract][Full Text] [Related]
34. Ursolic Acid Attenuates TGF-β1-Induced Epithelial-Mesenchymal Transition in NSCLC by Targeting Integrin αVβ5/MMPs Signaling.
Ruan JS; Zhou H; Yang L; Wang L; Jiang ZS; Sun H; Wang SM
Oncol Res; 2019 May; 27(5):593-600. PubMed ID: 28911340
[TBL] [Abstract][Full Text] [Related]
35. Apoptotic circulating tumor cells in early and metastatic breast cancer patients.
Kallergi G; Konstantinidis G; Markomanolaki H; Papadaki MA; Mavroudis D; Stournaras C; Georgoulias V; Agelaki S
Mol Cancer Ther; 2013 Sep; 12(9):1886-95. PubMed ID: 23778153
[TBL] [Abstract][Full Text] [Related]
36. V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells.
Schempp CM; von Schwarzenberg K; Schreiner L; Kubisch R; Müller R; Wagner E; Vollmar AM
Mol Cancer Ther; 2014 Apr; 13(4):926-37. PubMed ID: 24482380
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion.
Zheng H; Li Y; Wang Y; Zhao H; Zhang J; Chai H; Tang T; Yue J; Guo AM; Yang J
Toxicol Appl Pharmacol; 2014 Oct; 280(1):10-20. PubMed ID: 25094029
[TBL] [Abstract][Full Text] [Related]
38. Hesperidin suppresses the migration and invasion of non-small cell lung cancer cells by inhibiting the SDF-1/CXCR-4 pathway.
Xia R; Xu G; Huang Y; Sheng X; Xu X; Lu H
Life Sci; 2018 May; 201():111-120. PubMed ID: 29604270
[TBL] [Abstract][Full Text] [Related]
39. Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways.
Lai YH; Chen MH; Lin SY; Lin SY; Wong YH; Yu SL; Chen HW; Yang CH; Chang GC; Chen JJ
Oncotarget; 2015 Sep; 6(28):26252-65. PubMed ID: 26312766
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
